NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry Products and leadership of the FDA Center for Drug Evaluation and Research (CDER) ...

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic ...

NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry Products and leadership of the FDA Center for Drug Evaluation and Research (CDER) ...

John D. Rockefeller Sr. didn't just amass wealth — he helped invent modern philanthropy, using science and strategy to expand opportunity beyond the industrial elite. The Rockefeller Foundation helped ...

DAYTONA BEACH — On a table at Ricky Stenhouse Jr.’s home sits a photo of Dale Earnhardt Sr. and Stenhouse — when he was just 3 or 4 years old and long before he raced for a living. “I’ve got pictures ...

(MENAFN- Investor Brand Network) NRx Pharmaceuticals (NASDAQ: NRXP) announced completion of an in-person Type C guidance meeting with the U.S. Food and Drug Administration, attended by leadership from ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) said it received guidance from the U.S. Food and Drug Administration that could allow the company to file a New Drug Application for NRX-100 ...

Patriots give ex-Vikings WR one last shot on eve of Super Bowl 60 The New England Patriots have re-signed former Minnesota Vikings wideout Trent Sherfield to their practice squad ahead of Super Bowl ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening ...